Indivior Pharmaceuticals, Inc. INDV Rest of World — Net revenue

Similar metrics at other companies

LIVNRest of World — Net revenue

$109.42M+12.5%

MXLRest of world — Net revenue

$526K+41.8%

ARest Of World — Net revenue

$845.5M+11.0%

LULURest of World — Net revenue

$372M+13.4%

RMDRest of the World — Net revenue

$465.19M+9.1%

ST

STAsia and rest of world — Net revenue

$316.2M+6.1%

FAQ

What is Indivior Pharmaceuticals, Inc.'s rest of world — net revenue?

Indivior Pharmaceuticals, Inc. (INDV) reported rest of world — net revenue of $45M in Q1 2026.

How has Indivior Pharmaceuticals, Inc.'s rest of world — net revenue changed year-over-year?

Indivior Pharmaceuticals, Inc.'s rest of world — net revenue increased by 2.3% year-over-year, from $44M to $45M.

What is the long-term trend for Indivior Pharmaceuticals, Inc.'s rest of world — net revenue?

Over 3 years (2022 to 2025), Indivior Pharmaceuticals, Inc.'s rest of world — net revenue has grown at a 3.2% compound annual growth rate (CAGR), from $169M to $186M.

What does rest of world — net revenue mean?

This metric represents the total net sales generated from pharmaceutical products within all geographic regions outside of the company's primary domestic and secondary core markets. It reflects the company's ability to commercialize its portfolio of substance use disorder and mental health treatments on a global scale. Tracking this revenue stream helps investors assess the geographic diversification and international growth potential of the business.